Mark R. Nathan

942 total citations
5 papers, 202 citations indexed

About

Mark R. Nathan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mark R. Nathan has authored 5 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in Mark R. Nathan's work include Advanced Breast Cancer Therapies (1 paper), Cancer Research and Treatments (1 paper) and Renal cell carcinoma treatment (1 paper). Mark R. Nathan is often cited by papers focused on Advanced Breast Cancer Therapies (1 paper), Cancer Research and Treatments (1 paper) and Renal cell carcinoma treatment (1 paper). Mark R. Nathan collaborates with scholars based in United Kingdom and Belgium. Mark R. Nathan's co-authors include Peter Schmid, Victoria L. Bridgeman, Shane Foo, Caroline J. Springer, Sophia Frentzas, Jonathan Welti, Paul Nathan, Andrew R. Reynolds, Natasha Preece and Peter Vermeulen and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and The Breast.

In The Last Decade

Mark R. Nathan

5 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Nathan United Kingdom	3	93	71	56	55	36	5	202
Valeria Sanabria Guillen United States	8	157 1.7×	83 1.2×	41 0.7×	68 1.2×	34 0.9×	9	255
Edward Grimley United States	10	178 1.9×	56 0.8×	22 0.4×	27 0.5×	60 1.7×	11	249
A. Seun Ajiboye United States	4	170 1.8×	85 1.2×	193 3.4×	42 0.8×	65 1.8×	6	359
Courtney L. Andersen United States	8	144 1.5×	69 1.0×	21 0.4×	68 1.2×	40 1.1×	17	290
Patrícia Izetti Brazil	6	217 2.3×	140 2.0×	39 0.7×	59 1.1×	148 4.1×	6	364
Kuikui Jiang China	9	81 0.9×	96 1.4×	51 0.9×	14 0.3×	73 2.0×	30	227
Marty J. Heslin United States	5	245 2.6×	104 1.5×	20 0.4×	18 0.3×	51 1.4×	7	329
Vasilena Zheleva United States	6	126 1.4×	155 2.2×	67 1.2×	16 0.3×	115 3.2×	6	301
Hongjian Yang China	10	234 2.5×	62 0.9×	34 0.6×	24 0.4×	160 4.4×	20	313

Countries citing papers authored by Mark R. Nathan

Since Specialization

Citations

This map shows the geographic impact of Mark R. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Nathan more than expected).

Fields of papers citing papers by Mark R. Nathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Nathan. The network helps show where Mark R. Nathan may publish in the future.

Co-authorship network of co-authors of Mark R. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Nathan. A scholar is included among the top collaborators of Mark R. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Nathan. Mark R. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Verrill, Mark, Laura Pettit, Tamas Hickish, et al.. (2023). Abstract P6-01-11: A UK prospective multicentre decision impact, decision conflict and economic evaluation of the use of Oncotype DX® to guide chemotherapy in 680 women with hormone receptor positive, HER2 negative breast cancer and 1 to 3 nodes involved. Cancer Research. 83(5_Supplement). P6–1. 1 indexed citations

2.

Nathan, Mark R. & Peter Schmid. (2017). A Review of Fulvestrant in Breast Cancer. Oncology and Therapy. 5(1). 17–29. 128 indexed citations

3.

Nathan, Mark R. & Peter Schmid. (2017). The emerging world of breast cancer immunotherapy. The Breast. 37. 200–206. 34 indexed citations

4.

Nathan, Mark R., et al.. (2016). Abstract 4105: Dissecting the mechanisms of hepatocyte replacement in breast cancer liver metastases. Cancer Research. 76(14_Supplement). 4105–4105. 1 indexed citations

5.

Bridgeman, Victoria L., Elaine Y. Wan, Shane Foo, et al.. (2015). Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 15(1). 172–183. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact